|
CHD4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.195200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.769800E-04 |
| Normal-vs-Stage2 |
1.244210E-02 |
| Normal-vs-Stage3 |
5.551400E-01 |
| Normal-vs-Stage4 |
3.582400E-01 |
| Stage1-vs-Stage2 |
9.935000E-01 |
| Stage1-vs-Stage3 |
4.751700E-02 |
| Stage1-vs-Stage4 |
5.701800E-01 |
| Stage2-vs-Stage3 |
1.242180E-01 |
| Stage2-vs-Stage4 |
6.129600E-01 |
| Stage3-vs-Stage4 |
5.323400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.785500E-04 |
| Normal-vs-AfricanAmerican |
9.880500E-02 |
| Normal-vs-Asian |
1.584750E-01 |
| Caucasian-vs-AfricanAmerican |
2.187000E-01 |
| Caucasian-vs-Asian |
9.256800E-01 |
| AfricanAmerican-vs-Asian |
7.591000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.6782000000013E-05 |
| Normal-vs-Female |
6.690200E-01 |
| Male-vs-Female |
1.62803999999017E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.973700E-02 |
| Normal-vs-Extreme_Weight |
1.61367000000023E-05 |
| Normal-vs-Obese |
1.549050E-01 |
| Normal-vs-Extreme_Obese |
1.763510E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.326300E-02 |
| Normal_Weight-vs-Obese |
4.772800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.684040E-01 |
| Extreme_Weight-vs-Obese |
3.604500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.093000E-01 |
| Obese-vs-Extreme_Obese |
1.164420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.272600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.123500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.986300E-04 |
| Normal-vs-Age(81-100Yrs) |
1.616810E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.699800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.397700E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.881700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.917500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.308300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.182600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.422730E-03 |
| Normal-VS-Type2 PRCC |
6.402600E-03 |
| Normal-VS-KIRP CIMP |
4.409600E-01 |
| Normal-VS-Unclassified PRCC |
4.177400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.138400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.584100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.067360E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.862200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.925600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.471000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.820900E-04 |
| Normal-vs-N1 |
6.212400E-01 |
| Normal-vs-N2 |
7.143800E-01 |
| N0-vs-N1 |
2.921000E-03 |
| N0-vs-N2 |
1.073230E-01 |
| N1-vs-N2 |
9.899200E-01 |
|
|
